Jeffrey V. Poulton, EVP and Chief Financial Officer of Alnylam Pharmaceuticals ($ALNY), made 60 open market sales of company shares over the past year, totaling nearly $6 million. His latest sale occurred on March 4, 2026. These transactions rank him 1698th out of 11,678 insiders by total value sold, compared to an average of $8.6 million across 6.4 sales per insider. Poulton recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 109 | $320.01 | 64,107.0000 | 134,684,000 | 0.17% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 114 | $319.03 | 64,216.0000 | 134,684,000 | 0.18% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 223 | $325.67 | 61,862.0000 | 134,684,000 | 0.36% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 291 | $324.88 | 62,085.0000 | 134,684,000 | 0.47% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 818 | $323.84 | 62,376.0000 | 134,684,000 | 1.29% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 374 | $323.01 | 63,194.0000 | 134,684,000 | 0.59% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 309 | $321.82 | 63,568.0000 | 134,684,000 | 0.48% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 230 | $320.81 | 63,877.0000 | 134,684,000 | 0.36% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 124 | $324.65 | 66,347.0000 | 134,684,000 | 0.19% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 541 | $326.81 | 65,450.0000 | 134,684,000 | 0.82% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 454 | $327.67 | 64,996.0000 | 134,684,000 | 0.69% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 138 | $328.71 | 64,858.0000 | 134,684,000 | 0.21% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 234 | $329.71 | 64,624.0000 | 134,684,000 | 0.36% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 112 | $330.85 | 64,512.0000 | 134,684,000 | 0.17% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 129 | $331.93 | 64,383.0000 | 134,684,000 | 0.20% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 53 | $332.64 | 64,330.0000 | 134,684,000 | 0.08% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 10480 | $0.00 | 10,480.0000 | 134,684,000 | 9999.99% | 0.01% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 4769 | $0.00 | 66,536.0000 | 134,684,000 | 7.72% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 65 | $323.62 | 66,471.0000 | 134,684,000 | 0.10% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 356 | $325.63 | 65,991.0000 | 134,684,000 | 0.54% | 0.00% |
| Feb. 27, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | M | Restricted Stock Units | 1908 | $0.00 | 0.0000 | 134,684,000 | 100.00% | 0.00% |
| Feb. 27, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | M | Common Stock | 1908 | $0.00 | 61,767.0000 | 134,684,000 | 3.19% | 0.00% |
| Feb. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 4579 | $0.00 | 62,101.0000 | 134,684,000 | 7.96% | 0.00% |
| Feb. 13, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 2242 | $310.08 | 59,859.0000 | 134,684,000 | 3.61% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 87 | $363.55 | 58,831.0000 | 134,684,000 | 0.15% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 27 | $377.82 | 57,522.0000 | 134,684,000 | 0.05% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 34 | $375.65 | 57,549.0000 | 134,684,000 | 0.06% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 25 | $374.44 | 57,583.0000 | 134,684,000 | 0.04% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 6 | $372.46 | 57,608.0000 | 134,684,000 | 0.01% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 36 | $370.87 | 57,614.0000 | 134,684,000 | 0.06% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 73 | $369.48 | 57,650.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 170 | $368.62 | 57,723.0000 | 134,684,000 | 0.29% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 76 | $367.40 | 57,893.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 92 | $366.41 | 57,969.0000 | 134,684,000 | 0.16% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 405 | $365.56 | 58,061.0000 | 134,684,000 | 0.69% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 365 | $364.83 | 58,466.0000 | 134,684,000 | 0.62% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 135 | $362.38 | 58,918.0000 | 134,684,000 | 0.23% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 181 | $361.45 | 59,053.0000 | 134,684,000 | 0.31% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 284 | $360.22 | 59,234.0000 | 134,684,000 | 0.48% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 156 | $359.14 | 59,518.0000 | 134,684,000 | 0.26% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 226 | $358.18 | 59,674.0000 | 134,684,000 | 0.38% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 176 | $357.17 | 59,900.0000 | 134,684,000 | 0.29% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 76 | $356.09 | 60,076.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 78 | $355.16 | 60,152.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 72 | $353.95 | 60,230.0000 | 134,684,000 | 0.12% | 0.00% |
| Jan. 11, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 6193 | $0.00 | 60,302.0000 | 134,684,000 | 11.45% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 191 | $457.43 | 54,113.0000 | 137,348,000 | 0.35% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 95 | $455.82 | 54,304.0000 | 137,348,000 | 0.17% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 317 | $454.84 | 54,399.0000 | 137,348,000 | 0.58% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 150 | $446.53 | 57,780.0000 | 137,348,000 | 0.26% | 0.00% |
| Oct. 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 4644 | $0.00 | 57,930.0000 | 137,348,000 | 8.72% | 0.00% |
| Oct. 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 3108 | $0.00 | 53,286.0000 | 137,348,000 | 6.19% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 234 | $448.77 | 57,473.0000 | 137,348,000 | 0.41% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 324 | $449.79 | 57,149.0000 | 137,348,000 | 0.56% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 704 | $450.81 | 56,445.0000 | 137,348,000 | 1.23% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 428 | $453.77 | 54,716.0000 | 137,348,000 | 0.78% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 869 | $452.69 | 55,144.0000 | 137,348,000 | 1.55% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 4 | $457.64 | 54,109.0000 | 137,348,000 | 0.01% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 432 | $451.86 | 56,013.0000 | 137,348,000 | 0.77% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 73 | $447.92 | 57,707.0000 | 137,348,000 | 0.13% | 0.00% |
| Aug. 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 4644 | $0.00 | 52,452.0000 | 127,651,000 | 9.71% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 19 | $455.82 | 50,178.0000 | 127,651,000 | 0.04% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 392 | $454.84 | 50,197.0000 | 127,651,000 | 0.77% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 886 | $454.04 | 50,589.0000 | 127,651,000 | 1.72% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 536 | $452.96 | 51,475.0000 | 127,651,000 | 1.03% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 168 | $451.99 | 52,011.0000 | 127,651,000 | 0.32% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 63 | $450.92 | 52,179.0000 | 127,651,000 | 0.12% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 147 | $449.92 | 52,242.0000 | 127,651,000 | 0.28% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 63 | $447.98 | 52,389.0000 | 127,651,000 | 0.12% | 0.00% |
| June 23, 2025 | CervoMed Inc. | $CRVO | Poulton Jeffrey V. | Director | A | Stock Option (Right to Buy) | 8100 | $0.00 | 8,100.0000 | 8,702,719 | 9999.99% | 0.09% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 9800 | $0.00 | 9,800.0000 | 127,651,000 | 9999.99% | 0.01% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 15117 | $0.00 | 49,072.0000 | 127,651,000 | 44.52% | 0.01% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 350 | $242.37 | 48,722.0000 | 127,651,000 | 0.71% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 382 | $243.36 | 48,340.0000 | 127,651,000 | 0.78% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 258 | $244.41 | 48,082.0000 | 127,651,000 | 0.53% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 189 | $245.26 | 47,893.0000 | 127,651,000 | 0.39% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 77 | $246.18 | 47,816.0000 | 127,651,000 | 0.16% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 7 | $247.35 | 47,809.0000 | 127,651,000 | 0.01% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 1 | $248.36 | 47,808.0000 | 127,651,000 | 0.00% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 34 | $238.33 | 34,675.0000 | 127,651,000 | 0.10% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 35 | $239.18 | 34,640.0000 | 127,651,000 | 0.10% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 78 | $240.32 | 34,562.0000 | 127,651,000 | 0.23% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 127 | $241.51 | 34,435.0000 | 127,651,000 | 0.37% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 300 | $242.44 | 34,135.0000 | 127,651,000 | 0.87% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 121 | $243.23 | 34,014.0000 | 127,651,000 | 0.35% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 59 | $244.11 | 33,955.0000 | 127,651,000 | 0.17% | 0.00% |
| Feb. 27, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | M | Restricted Stock Units | 1908 | $0.00 | 1,908.0000 | 127,651,000 | 50.00% | 0.00% |
| Feb. 27, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | M | Common Stock | 1908 | $0.00 | 34,751.0000 | 127,651,000 | 5.81% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 42 | $236.51 | 34,709.0000 | 127,651,000 | 0.12% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 30 | $260.57 | 32,917.0000 | 127,651,000 | 0.09% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 37 | $261.45 | 32,880.0000 | 127,651,000 | 0.11% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 20 | $264.87 | 32,843.0000 | 127,651,000 | 0.06% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 17 | $263.33 | 32,863.0000 | 127,651,000 | 0.05% | 0.00% |
| Feb. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 3109 | $0.00 | 33,810.0000 | 127,651,000 | 10.13% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 217 | $252.50 | 33,593.0000 | 127,651,000 | 0.64% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 239 | $253.37 | 33,354.0000 | 127,651,000 | 0.71% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 160 | $254.35 | 33,194.0000 | 127,651,000 | 0.48% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 68 | $255.56 | 33,126.0000 | 127,651,000 | 0.20% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 78 | $256.29 | 33,048.0000 | 127,651,000 | 0.24% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 37 | $257.51 | 33,011.0000 | 127,651,000 | 0.11% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 47 | $258.07 | 32,964.0000 | 127,651,000 | 0.14% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 17 | $259.72 | 32,947.0000 | 127,651,000 | 0.05% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 97 | $252.27 | 30,701.0000 | 128,590,000 | 0.31% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 945 | $251.42 | 30,798.0000 | 128,590,000 | 2.98% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 364 | $250.68 | 31,743.0000 | 128,590,000 | 1.13% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 246 | $249.60 | 32,107.0000 | 128,590,000 | 0.76% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 30 | $247.77 | 32,353.0000 | 128,590,000 | 0.09% | 0.00% |
| Nov. 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 3434 | $0.00 | 32,383.0000 | 128,590,000 | 11.86% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 167 | $235.19 | 28,949.0000 | 124,906,000 | 0.57% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 18 | $225.55 | 30,464.0000 | 124,906,000 | 0.06% | 0.00% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 3278 | $0.00 | 30,554.0000 | 124,906,000 | 12.02% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 59 | $221.71 | 30,495.0000 | 124,906,000 | 0.19% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 13 | $224.17 | 30,482.0000 | 124,906,000 | 0.04% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 34 | $226.82 | 30,430.0000 | 124,906,000 | 0.11% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 129 | $228.30 | 30,301.0000 | 124,906,000 | 0.42% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 266 | $229.06 | 30,035.0000 | 124,906,000 | 0.88% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 304 | $229.93 | 29,731.0000 | 124,906,000 | 1.01% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 99 | $231.59 | 29,632.0000 | 124,906,000 | 0.33% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 216 | $232.54 | 29,416.0000 | 124,906,000 | 0.73% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 115 | $233.53 | 29,301.0000 | 124,906,000 | 0.39% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 185 | $234.66 | 29,116.0000 | 124,906,000 | 0.63% | 0.00% |
| June 14, 2024 | CervoMed Inc. | $CRVO | Poulton Jeffrey V. | Director | A | Stock Option (Right to Buy) | 5750 | $0.00 | 5,750.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 7741 | $0.00 | 27,276.0000 | 124,906,000 | 39.63% | 0.01% |
| March 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 15118 | $0.00 | 15,118.0000 | 124,906,000 | 9999.99% | 0.01% |
| Feb. 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | M | Common Stock | 1908 | $0.00 | 20,109.0000 | 124,906,000 | 10.48% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 247 | $154.54 | 19,862.0000 | 124,906,000 | 1.23% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 194 | $155.45 | 19,668.0000 | 124,906,000 | 0.98% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 115 | $156.38 | 19,553.0000 | 124,906,000 | 0.58% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 17 | $157.30 | 19,536.0000 | 124,906,000 | 0.09% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 1 | $158.09 | 19,535.0000 | 124,906,000 | 0.01% | 0.00% |
| Feb. 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | M | Restricted Stock Units | 1908 | $0.00 | 3,816.0000 | 124,906,000 | 33.33% | 0.00% |
| Feb. 15, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | A | Common Stock | 3278 | $0.00 | 19,208.0000 | 124,906,000 | 20.58% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 120 | $149.03 | 18,201.0000 | 124,906,000 | 0.65% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 518 | $148.24 | 18,321.0000 | 124,906,000 | 2.75% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Poulton Jeffrey V. | EVP, Chief Financial Officer | S | Common Stock | 369 | $147.50 | 18,839.0000 | 124,906,000 | 1.92% | 0.00% |
| June 14, 2023 | Q32 Bio Inc. | $QTTB | Poulton Jeffrey V. | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |